BRIEF published on 07/19/2024 at 07:35, 1 year 8 months ago Nicox: Participation in upcoming conferences Conférences 2024 Investments Ophthalmology Nicox
PRESS RELEASE published on 07/19/2024 at 07:30, 1 year 8 months ago Nicox announces attendance at upcoming conferences Nicox announces attendance at upcoming international conferences, including H.C. Wainwright 4th Annual Ophthalmology Virtual Conference and AAO 2024 Clinical Development International Conférences Ophthalmology Nicox
BRIEF published on 07/18/2024 at 07:35, 1 year 8 months ago Nicox Provides Second Quarter 2024 Update Q2 2024 Financial Update Ophthalmology Nicox NCX 470
PRESS RELEASE published on 07/18/2024 at 07:30, 1 year 8 months ago Nicox Provides Second Quarter 2024 Update Nicox reports €1.6M revenue & €7.8M cash for Q2 2024, extending funds until Feb 2025. Focus on NCX 470 development & Denali trial progress. New Board members appointed Revenue Cash Position Nicox NCX 470 Denali Trial
BRIEF published on 07/16/2024 at 07:35, 1 year 8 months ago Nicox appoints Damian Marron Chairman of the Board of Directors Board Of Directors Ophthalmology Nicox Marc Le Bozec Damian Brown
PRESS RELEASE published on 07/16/2024 at 07:30, 1 year 8 months ago Nicox appoints experienced biotech leader Damian Marron as Chair of the Board and Marc Le Bozec as Director Nicox appoints Damian Marron as Chair of the Board and Marc Le Bozec as Director. Experienced leaders join Nicox Board, Labbe and Kaplan step down. Strategic shift in leadership Board Of Directors Healthcare Nicox Damian Marron Marc Le Bozec
BRIEF published on 06/19/2024 at 07:35, 1 year 9 months ago Nicox succeeds in its capital increase of 3.3 million euros Increase In Capital Ophthalmology Nicox NCX 470 Ocumension Therapeutics
BRIEF published on 06/03/2024 at 07:35, 1 year 9 months ago Nicox SA Announces Voting Rights as of May 31, 2024 Euronext Growth Paris Share Capital Voting Rights AMF Nicox
PRESS RELEASE published on 06/03/2024 at 07:30, 1 year 9 months ago Number of voting rights as of May 31, 2024 Nicox SA monthly publication of the number of shares and voting rights. Details on market, ISIN code, and company's lead programs Voting Rights Shares Ophthalmology Monthly Publication Nicox SA
BRIEF published on 05/31/2024 at 07:35, 1 year 9 months ago Nicox is hosting a webcast for its shareholders on June 6, 2024 Shareholders Webcast Increase In Capital Ophthalmology Nicox
Published on 03/26/2026 at 16:20, 2 hours 25 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 5 hours 45 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 5 hours 45 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 5 hours 46 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 18:29, 15 minutes ago IEVA GROUP: IEVA Group is listing on Euronext Growth® Paris to accelerate its growth and innovation strategy
Published on 03/26/2026 at 18:13, 32 minutes ago EQS-Adhoc: Allgeier SE: Allgeier meets its earnings guidance for 2025 and is strengthening its focus on AI-based platform technologies and software solutions
Published on 03/26/2026 at 17:51, 54 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/26/2026 at 17:45, 1 hour ago CTS EVENTIM exceeds EUR 3 billion in revenue for the first time, sustaining profitable growth
Published on 03/26/2026 at 07:30, 11 hours 15 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
